NIH Encouraged To Break Gilead’s Patent On HIV Prevention Drug.
March 05, 2019
Fortune (3/4, Shoot) reports Gilead Sciences’ HIV prevention treatment Truvada (emtricitabine/tenofovir disoproxil fumarate), “the only drug approved by the United States Food and Drug Administration...for pre-exposure prophylaxis, or PrEP,” is the subjec...